Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients
Authors
Keywords
Hemodialysis, Lipoproteins, Inflammation, Lipoprotein-associated phospholipase A<sub>2</sub>
Journal
JOURNAL OF NEPHROLOGY
Volume 28, Issue 6, Pages 749-755
Publisher
Springer Nature
Online
2015-05-14
DOI
10.1007/s40620-015-0194-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease
- (2014) Ron C. Hoogeveen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Higher levels of small dense low-density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with Type 2 diabetes
- (2013) E.-H. Jang et al. DIABETIC MEDICINE
- Lipoprotein-Associated Phospholipase A2 (Lp-PLA2): A Novel and Promising Biomarker for Cardiovascular Risks Assessment
- (2013) Anping Cai et al. DISEASE MARKERS
- Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients
- (2013) Przemysław Pencak et al. BMC Nephrology
- Uremia Alters HDL Composition and Function
- (2011) M. Holzer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lipid profiles and oxidative stress parameters in male and female hemodialysis patients
- (2011) A. Osorio et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms
- (2011) Mohamad Navab et al. Nature Reviews Cardiology
- ApoA-1 Mimetic Peptide Reverses Uremia-Induced Upregulation of Pro-Atherogenic Pathways in the Aorta
- (2010) Nosratola D. Vaziri et al. AMERICAN JOURNAL OF NEPHROLOGY
- Lipoprotein subfractions and cardiovascular disease risk
- (2010) Ronald M Krauss CURRENT OPINION IN LIPIDOLOGY
- Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease
- (2010) P. Stenvinkel JOURNAL OF INTERNAL MEDICINE
- Inflammation Impairs Reverse Cholesterol Transport In Vivo
- (2009) Fiona C. McGillicuddy et al. CIRCULATION
- Inflammation in Atherosclerosis
- (2009) Peter Libby et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide
- (2009) Nosratola D. Vaziri et al. KIDNEY INTERNATIONAL
- Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A2 Testing into Cardiovascular Disease Risk Assessment Guidelines
- (2008) Michael H. Davidson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice
- (2008) Tanja X. Pedersen et al. ATHEROSCLEROSIS
- Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome
- (2008) Manfredi Rizzo et al. CLINICAL ENDOCRINOLOGY
- Emerging Biomarkers for Evaluating Cardiovascular Risk in the Chronic Kidney Disease Patient: How Do New Pieces Fit into the Uremic Puzzle?
- (2008) P. Stenvinkel et al. Clinical Journal of the American Society of Nephrology
- Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins
- (2008) A. R. Tall JOURNAL OF INTERNAL MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started